Colonoscopy Screening for Average-Risk Adults (Age 45-75)
For average-risk adults, begin colorectal cancer screening at age 45 with colonoscopy every 10 years or annual fecal immunochemical testing (FIT), continuing through age 75 in those with life expectancy >10 years. 1
When to Start Screening
- Begin at age 45 years for all average-risk adults, though this is a qualified recommendation with the strongest evidence supporting screening from age 50 1
- The U.S. Multi-Society Task Force provides a strong recommendation for age 50 (high-quality evidence) but a weak recommendation for ages 45-49 (low-quality evidence) 1
- The USPSTF gives a Grade A recommendation for ages 50-75 and a Grade B recommendation for ages 45-49 1
When to Stop Screening
- Continue screening through age 75 in adults with good health and life expectancy >10 years 1
- Ages 76-85: Individualize decisions based on prior screening history, overall health status, comorbidities, and patient preferences—adults who have never been screened are more likely to benefit 1
- Age 86 and older: Do not offer screening, as mortality risks and adverse events outweigh benefits 1
- Discontinue screening when life expectancy falls below 10 years regardless of age 1
Screening Test Options and Intervals
First-Tier Options (Strongest Recommendations)
These two modalities are recommended as first-tier options with strong evidence supporting their use 1
Second-Tier Options
- CT colonography every 5 years 1
- Multitarget stool DNA test every 3 years 1
- Flexible sigmoidoscopy every 5 years 1
Key Principle
All positive results on non-colonoscopy screening tests must be followed up with timely colonoscopy 1
Bowel Preparation Guidelines
- Use split-dose or same-day dosing for optimal preparation quality and patient tolerance 1, 2
- Low-volume regimens are preferred to improve compliance 2
- For patients at high risk for inadequate preparation: consider split-dose 4L PEG-ELS plus 15 mg bisacodyl the afternoon before, with low-residue diet 3 and 2 days before, transitioning to clear liquids the day before 1
Quality Metrics
- Adenoma detection rate (ADR) must be measured and should meet minimum thresholds: ≥30% in men and ≥20% in women, with aspirational targets approaching 50% in screening patients 1, 2
- Cecal intubation must be achieved for complete examination 2
- Adequate withdrawal time with compulsive inspection of all mucosal surfaces is mandatory 2
Management of Inadequate Preparation
- Repeat colonoscopy within 1 year if bowel preparation is inadequate 1
- If only the right colon had inadequate preparation but left colon/rectum were well-visualized, consider offering alternative screening options (FIT, stool DNA testing) rather than immediate repeat colonoscopy 1
- Patients with prior inadequate preparation should receive modified bowel preparation regimens as described above 1
Important Caveats
- African Americans: Some guidelines suggest considering screening at age 45 based on higher CRC incidence and mortality rates, though evidence is limited 1
- Family history considerations: This guidance applies only to average-risk individuals—those with first-degree relatives with CRC or advanced adenomas require earlier and more frequent screening (typically starting at age 40 or 10 years before the youngest affected relative's diagnosis) 1, 3
- Rising incidence in younger adults: CRC incidence has increased 51% in adults under 55 from 1994-2014, supporting the lowered screening age 1
- The Canadian Task Force (CTFPHC) recommends against colonoscopy as a screening test, preferring FOBT or flexible sigmoidoscopy, but this represents an outlier position not supported by U.S. guidelines 1